Suchergebnisse - "Pogue, Jason M"

PubPharm (223)

11

Case Commentary : When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Wangchinda, W. | Pogue, J.

12

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia

enthalten in: Open forum infectious diseases | 2023

von Tran, N. | Mynatt, R. | Kaye, K. | +2

ErratumIn: Open Forum Infect Dis. 2023 Jun 13;10(6):ofad309. - PMID 37323426

13

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales

enthalten in: Infectious diseases and therapy | 2023

von Kaye, K. | Naas, T. | Pogue, J. | +1

14

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales

enthalten in: Infectious diseases and therapy | 2023

von Kaye, K. | Naas, T. | Pogue, J. | +1

15

Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Albin, O. | Kaye, K. | McCreary, E. | +1

CommentIn: Clin Infect Dis. 2022 Oct 05;:. - PMID 36196675

16

Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

enthalten in: NEJM evidence | 2023

von Kaye, K. | Marchaim, D. | Thamlikitkul, V. | +28

17

Monoclonals for patients hospitalised with COVID-19

enthalten in: The Lancet. Respiratory medicine | 2022

von Pogue, J. | McCreary, E.

CommentOn: Lancet Respir Med. 2022 Oct;10(10):972-984. - PMID 35817072

18

Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis

enthalten in: JAMA internal medicine | 2022

von Prescott, H. | Seelye, S. | Wang, X. | +9

19

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020) : Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints

enthalten in: Microbiology spectrum | 2022

von Gupta, V. | Yu, K. | Pogue, J. | +2

20

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals

enthalten in: Antimicrobial stewardship & healthcare epidemiology : ASHE | 2022

von Mahoney, M. | Bhagat, H. | Christian, R. | +4